Researchers are calling for a revised criterion of what constitutes polycystic ovary morphology based on what is observed on ultrasound among patients after age 30 to 35 years, according to data ...

Researchers in France have developed an antibody that blocks AMH, reversing PCOS symptoms in mice and opening the door to future human trials.

Polycystic ovarian morphology was not included as a diagnostic criterion because it was already established that this morphology was a nonspecific finding that was also present in 20% to 30% of ...

A complex endocrine disorder with genetic roots, affecting women's health and fertility, requiring early intervention.

Polycystic ovary syndrome (PCOS) affects approximately 6% to 20% of women of reproductive age depending on diagnostic criteria. 1 Though symptoms typically manifest during early pubertal years ...

The research revealed widespread disruptions in the activity of genes responsible for early embryonic genome activation, metabolic processes, epigenetic regulation, and chromatin structure in embryos ...